Multiple Myeloma

Symptoms

Common signs and symptoms of Multiple Myeloma include:

Bone pain, especially in the back or ribs

Frequent infections that take longer to clear

Unexplained fatigue and weakness

Excessive bleeding or easy bruising

Excessive thirst and frequent urination

Nausea and loss of appetite

Weight loss without trying

Confusion or mental fogginess

Shortness of breath during normal activities

Numbness or tingling in hands and feet

Kidney problems or decreased urination

Fractures from minor injuries or falls

When to see a doctor

If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.

Causes & Risk Factors

Several factors can contribute to Multiple Myeloma.

Multiple myeloma develops when plasma cells - specialized white blood cells that normally produce antibodies - undergo genetic mutations that cause them to grow and divide uncontrollably.

Multiple myeloma develops when plasma cells - specialized white blood cells that normally produce antibodies - undergo genetic mutations that cause them to grow and divide uncontrollably. These abnormal cells accumulate in bone marrow, crowding out healthy blood cells and producing defective proteins called monoclonal proteins or M proteins.

The exact trigger for these genetic changes remains unknown.

The exact trigger for these genetic changes remains unknown. Scientists believe it likely involves a combination of genetic predisposition and environmental factors, though no single cause has been identified. The mutations typically accumulate over time, which explains why the disease predominantly affects older adults.

Unlike some cancers that have clear hereditary patterns, multiple myeloma rarely runs directly in families.

Unlike some cancers that have clear hereditary patterns, multiple myeloma rarely runs directly in families. However, having a first-degree relative with the condition does slightly increase risk, suggesting some genetic susceptibility exists alongside other factors that researchers continue to study.

Risk Factors

Age over 65 years
Male gender
Black or African American ethnicity
History of MGUS (monoclonal gammopathy of undetermined significance)
Previous plasma cell disorder or plasmacytoma
Family history of multiple myeloma
Exposure to high levels of radiation
Obesity throughout adulthood
Immune system disorders or immunosuppressive therapy

Diagnosis

How healthcare professionals diagnose Multiple Myeloma:

1
Diagnosing multiple myeloma often begins when routine blood work reveals abnormal protein levels or when patients seek help for persistent bone pain or frequent infections.
Diagnosing multiple myeloma often begins when routine blood work reveals abnormal protein levels or when patients seek help for persistent bone pain or frequent infections. Many cases are discovered incidentally during testing for other health concerns, since early symptoms can be subtle or mistaken for normal aging.
2
The diagnostic process typically includes several key tests.
The diagnostic process typically includes several key tests. Blood tests measure protein levels, kidney function, calcium levels, and complete blood counts. A 24-hour urine collection checks for abnormal proteins being filtered by the kidneys. Bone marrow biopsy - usually taken from the hip bone - confirms the presence and percentage of cancerous plasma cells. Imaging studies like X-rays, CT scans, or MRI help identify bone damage or lesions throughout the skeleton.
3
Doctors also test for specific genetic markers and chromosomal abnormalities that help determine prognosis and guide treatment decisions.
Doctors also test for specific genetic markers and chromosomal abnormalities that help determine prognosis and guide treatment decisions. The combination of these results, along with symptoms and physical examination findings, allows specialists to not only confirm the diagnosis but also determine the stage and risk category of the disease.

Complications

Multiple myeloma can affect multiple organ systems, with bone problems being among the most common and challenging complications.
The cancer cells release substances that break down bone faster than it can rebuild, leading to pain, fractures, and elevated calcium levels in the blood.
Kidney damage occurs in roughly half of patients, either from abnormal proteins clogging the filtering system or from high calcium levels.
The disease suppresses normal immune function, making patients more susceptible to serious infections.
Anemia develops as cancer cells crowd out red blood cell production, causing fatigue and shortness of breath.
Some patients develop blood clotting problems or peripheral neuropathy - nerve damage causing numbness and tingling in hands and feet, often related to certain treatments rather than the disease itself.

Prevention

Unlike some cancers with clear preventable risk factors, multiple myeloma has no proven prevention strategies since its exact causes remain unknown.
The strongest risk factors - age, gender, and ethnicity - cannot be modified, and most environmental connections remain unclear.
Maintaining overall health through regular exercise, a balanced diet, and avoiding obesity may provide some benefit, as obesity has been linked to slightly increased risk.
Some studies suggest limiting exposure to certain chemicals and radiation when possible, though these connections aren't definitively established.
People with MGUS, a precursor condition, should follow their doctor's recommendations for regular monitoring.
The most practical approach focuses on staying alert to symptoms and maintaining regular healthcare.
Since multiple myeloma often develops from MGUS, people diagnosed with this benign condition should keep scheduled follow-up appointments to catch any progression early when treatment tends to be most effective.

Treatment Approaches

Treatment for multiple myeloma has evolved dramatically over the past two decades, transforming it from a rapidly fatal disease to a manageable chronic condition for many patients.

Treatment for multiple myeloma has evolved dramatically over the past two decades, transforming it from a rapidly fatal disease to a manageable chronic condition for many patients. The approach depends on factors like age, overall health, disease stage, and genetic characteristics of the cancer cells.

For younger, healthier patients, treatment often begins with several months of combination chemotherapy to reduce the cancer burden, followed by high-dose chemotherapy with stem cell transplant.

For younger, healthier patients, treatment often begins with several months of combination chemotherapy to reduce the cancer burden, followed by high-dose chemotherapy with stem cell transplant. This intensive approach can lead to long periods of remission. Older patients or those with other health conditions typically receive gentler but still effective combinations of newer targeted drugs like lenalidomide, bortezomib, or daratumumab along with steroids.

MedicationAnti-inflammatoryOncology

Maintenance therapy has become a standard part of care, where patients continue taking medications at lower doses after initial treatment to help prevent the cancer from returning.

Maintenance therapy has become a standard part of care, where patients continue taking medications at lower doses after initial treatment to help prevent the cancer from returning. These might include drugs like lenalidomide taken as daily pills for months or years. Additionally, supportive treatments address complications - bisphosphonates strengthen bones, antibiotics prevent infections, and medications manage anemia or kidney problems.

MedicationTherapyAntibiotic

Promising developments include CAR-T cell therapy, which engineers a patient's own immune cells to attack myeloma cells, and newer immunotherapies that help the immune system recognize and destroy cancer cells.

Promising developments include CAR-T cell therapy, which engineers a patient's own immune cells to attack myeloma cells, and newer immunotherapies that help the immune system recognize and destroy cancer cells. Clinical trials continue to test combinations of these innovative approaches, offering hope for even better outcomes in the future.

Therapy

Living With Multiple Myeloma

Living with multiple myeloma requires adapting to a new normal while maintaining quality of life. Many patients find that staying physically active, even with gentle exercises like walking or swimming, helps manage fatigue and maintain bone strength. Working closely with the healthcare team to manage side effects from treatments makes daily life more comfortable and sustainable.

Practical adjustments often help: - Using assistive devices if bone pain or fracPractical adjustments often help: - Using assistive devices if bone pain or fractures limit mobility - Practicing good hygiene and avoiding crowds during times when immune function is low - Planning activities around treatment schedules and energy levels - Joining support groups to connect with others facing similar challenges

Emotional support plays a crucial role in managing this chronic condition.Emotional support plays a crucial role in managing this chronic condition. Many patients benefit from counseling, either individually or with family members, to process the diagnosis and develop coping strategies. The uncertainty that comes with cancer can be particularly challenging, but focusing on what can be controlled - following treatment plans, maintaining relationships, and pursuing meaningful activities - often helps people find their footing in this new reality.

Latest Medical Developments

Latest medical developments are being researched.

Frequently Asked Questions

Is multiple myeloma always fatal?

Multiple myeloma remains incurable, but it's increasingly treated as a chronic disease that people can live with for many years. With modern treatments, many patients survive a decade or longer with good quality of life.

Can I still work after being diagnosed?

Many people continue working, either full-time or part-time, depending on their symptoms and treatment schedule. Fatigue and treatment appointments may require schedule adjustments, but staying productive often benefits overall well-being.

Will I need a bone marrow transplant?

Not everyone needs a transplant. The decision depends on age, overall health, and how well initial treatments work. Younger, healthier patients are more likely to be candidates for this intensive but potentially beneficial procedure.

How often will I need treatment?

Treatment schedules vary widely. Some people receive infusions monthly, others take daily oral medications, and many have periods of watch-and-wait between active treatments when the disease is stable.

Can I travel with multiple myeloma?

Most travel is possible with proper planning. Coordinate with your healthcare team about timing around treatments, bring adequate medications, and consider travel insurance that covers pre-existing conditions.

Should I avoid certain foods or activities?

No specific diet restrictions apply, though maintaining good nutrition supports overall health. Avoid activities with high fracture risk if bones are weakened, and practice extra infection precautions when immune function is low.

Will my family members develop multiple myeloma?

The risk to family members remains very small. While having a relative with multiple myeloma slightly increases risk, the vast majority of cases occur in people with no family history.

How will I know if treatments are working?

Regular blood tests and periodic bone marrow biopsies track M protein levels and cancer cell counts. Symptom improvement and stable imaging studies also indicate treatment response.

Can I have children after diagnosis?

Some treatments can affect fertility, so discuss family planning with your healthcare team before starting therapy. Fertility preservation options may be available if desired.

What happens if my current treatment stops working?

Multiple treatment options exist, and many people go through several different regimens over time. Drug resistance often develops gradually, allowing time to transition to alternative therapies.

Update History

Mar 9, 2026v1.0.0

Published page overview and treatments by DiseaseDirectory